Literature DB >> 34277003

Obesity and telomere status in the prognosis of patients with colorectal cancer submitted to curative intention surgical treatment.

Sergio García-Martínez1, Daniel González-Gamo1, Tamara Fernández-Marcelo1,2, Sofía Tesolato1, Sofía De La Serna3,4, Inmaculada Domínguez-Serrano3,4, Oscar Cano-Valderrama3,4, Ana Barabash2,4,5, Carmen De Juan1,4, Antonio Torres-García3,4, Pilar Iniesta1,4.   

Abstract

The risk of colorectal cancer (CRC) development has been associated with telomere dysfunction and obesity. However, clinical relevance of these parameters in CRC prognosis is not clear. Therefore, the aim of the present study was to evaluate the impact of obesity and telomere status in the prognosis of patients affected by CRC and submitted to curative surgical treatment. According to published data, this is the first work in which obesity and telomere status are jointly considered in relation to CRC prognosis. A prospective study including 162 patients with CRC submitted to curative surgical treatment was performed. Subjects were classified according to their BMI. Telomere status was established through telomere length and telomerase activity evaluation. Statistical analyses were performed using the SPSS software package version 22. Telomere shortening was inversely associated with BMI in patients with CRC. Notably, among patients with CRC, subjects with obesity exhibited less shortening of tumor telomeres than non-obese patients (P=0.047). Patients with shorter telomeres, both in the tumor (median telomere length <6.5 kb) and their non-tumor paired tissues (median telomere length <7.1 kb), had the best clinical evolution, regardless of the Dukes' stage of cancers (P=0.025, for tumor samples; P=0.003, for non-tumor samples). Additionally, subjects with a BMI >31.85 kg/m2 showed the worse clinical outcomes compared with subjects with other BMI values. Interestingly, the impact of BMI showed sex dependence, since only the group of men displayed significant differences in CRC prognosis in relation to obesity status (P=0.037). From the results of the present study, based on a multivariate prediction model to establish prognosis, it was concluded that telomere length is a useful biomarker to predict prognosis in patients with CRC. Regardless of BMI values, the improved clinical evolution was associated with shorter telomeres. The impact of BMI seems to be associated with other factors, such as sex.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  colorectal cancer; obesity; prognosis; telomerase; telomere

Year:  2021        PMID: 34277003      PMCID: PMC8278406          DOI: 10.3892/mco.2021.2346

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  35 in total

Review 1.  Mutations, Cancer and the Telomere Length Paradox.

Authors:  Abraham Aviv; James J Anderson; Jerry W Shay
Journal:  Trends Cancer       Date:  2017-03-27

Review 2.  Telomeres in cancer: tumour suppression and genome instability.

Authors:  John Maciejowski; Titia de Lange
Journal:  Nat Rev Mol Cell Biol       Date:  2017-01-18       Impact factor: 94.444

Review 3.  Telomeres, telomerase and colorectal cancer.

Authors:  Roberta Bertorelle; Enrica Rampazzo; Salvatore Pucciarelli; Donato Nitti; Anita De Rossi
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 4.  Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation.

Authors:  Neil M Iyengar; Ayca Gucalp; Andrew J Dannenberg; Clifford A Hudis
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

5.  Short telomeres limit tumor progression in vivo by inducing senescence.

Authors:  David M Feldser; Carol W Greider
Journal:  Cancer Cell       Date:  2007-04-12       Impact factor: 31.743

6.  Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.

Authors:  James J Dignam; Blase N Polite; Greg Yothers; Peter Raich; Linda Colangelo; Michael J O'Connell; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

Review 7.  Telomere Length as a Prognostic Factor for Overall Survival in Colorectal Cancer Patients.

Authors:  Houjun Jia; Ziwei Wang
Journal:  Cell Physiol Biochem       Date:  2016-01-08

8.  Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer.

Authors:  Cristina Frías; Cristina García-Aranda; Carmen De Juan; Alberto Morán; Paloma Ortega; Ana Gómez; Florentino Hernando; Jose-Antonio López-Asenjo; Antonio-José Torres; Manuel Benito; Pilar Iniesta
Journal:  Lung Cancer       Date:  2008-02-20       Impact factor: 5.705

Review 9.  Obesity and cancer risk: Emerging biological mechanisms and perspectives.

Authors:  Konstantinos I Avgerinos; Nikolaos Spyrou; Christos S Mantzoros; Maria Dalamaga
Journal:  Metabolism       Date:  2018-11-13       Impact factor: 8.694

10.  Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.

Authors:  Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James Thomas; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

View more
  1 in total

1.  Association of circulating leukocyte telomere length with survival in patients with colorectal cancer.

Authors:  Svenja Pauleck; Biljana Gigic; Richard M Cawthon; Jennifer Ose; Anita R Peoples; Christy A Warby; Jennifer A Sinnott; Tengda Lin; Juergen Boehm; Petra Schrotz-King; Christopher I Li; David Shibata; Erin M Siegel; Jane C Figueiredo; Adetunji T Toriola; Martin Schneider; Alexis B Ulrich; Albrecht Hoffmeister; Cornelia M Ulrich; Sheetal Hardikar
Journal:  J Geriatr Oncol       Date:  2022-01-05       Impact factor: 3.929

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.